
AI-enabled pharmacovigilance is becoming a commercial capability that protects product value and speeds evidence-based market access decisions.

Anamika Krishanpal, PhD, is a life sciences digital leader with over 15 years of experience operating at the intersection of biological domain science and digital engineering.

AI-enabled pharmacovigilance is becoming a commercial capability that protects product value and speeds evidence-based market access decisions.